Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Open-Label Study to Evaluate the Ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to Detect Tear Film Stability Utilizing Miebo®

NCT07790211 is registered in ClinicalTrials.gov with Vance Thompson Vision as lead sponsor.

NCT NCT07790211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07790211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Open-Label Study to Evaluate the Ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to Detect Tear Film Stability Utilizing Miebo®
Lead sponsor
Vance Thompson Vision
Phase
Phase 4
Overall status
Recruiting
Start date
August 31, 2026
Completion date
September 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye